To study the major histocompatibility complex class II I-E dependence of mouse mammary tumor virus (MMTV) superantigens, we constructed hybrids between the I-E-dependent MMTV(GR) and the I-E-independent mtv-7 superantigens and tested them in vivo. Our results suggest that, although the C-terminal third mediates I-A interaction, additional binding sites are located elsewhere in the superantigen.
Mouse mammary tumor virus (MMTV) encodes a superantigen (SAg). SAgs are presented by major histocompatibility complex (MHC) class II molecules at the cell surface and interact with subsets of T cells expressing specific variable domains of the T-cell receptor ␤ chain. MMTV SAgs can be divided into two groups, depending on their responses induced in I-E ϩ and I-E Ϫ mouse strains (reviewed in reference 8). One SAg group requires the expression of I-E for presentation (e.g., GR, C3H, SIM, and Tes2 and mtv -1, -6, -8, and -9) , whereas the other can be presented by either I-A or I-E (e.g., mtv-7, SW, SHN, Tes14, CS, and C4). The structural features conferring this difference remain unclear. We therefore studied hybrid molecules between the I-E-dependent GR and the I-Eindependent mtv-7 SAgs for their abilities to be presented by I-A by comparing their SAg responses in I-E ϩ I-A ϩ and I-E Ϫ I-A ϩ mice. Recombinant vaccinia virus (rVV) was chosen as a heterologous SAg expression system in vivo. In addition to the already described rVV expressing the I-E-dependent SAg of MMTV(GR) (vOGR1 [5, 6] ), herein called v-GR, we produced a new rVV for the I-E-independent SAg of mtv-7 (v-7) (Fig. 1) . To map sequences involved in I-A interaction, we further constructed rVVs for hybrid molecules between MMTV(GR) and mtv-7 SAgs. Since the comparison of protein sequences from I-E-dependent (GR, C3H, SIM, and Tes2 and mtv-1, -6, -8, and -9) and -independent viruses (mtv-7, SW, SHN, Tes14, CS, and C4) did not reveal any possible consensus site for MHC class II I-A binding, we divided the extracellular part of the MMTV SAgs into thirds and produced six rVVs expressing hybrid SAgs with all combinations of them ( Fig. 2A , v-7G1 to v-7G6).
The overall expression of the viral SAg by the rVVs was evaluated by immunoprecipitation of total lysates of CV1 cells (Fig. 2B) . VV wild-type-infected cells were used as a negative control. Two major bands and one minor band were seen for each rVV around the size of 46 kDa, as previously described (5) . v-7G3, -7G4, and -7G6 produced bands similar to the parental v-7, whereas v-7G1, -7G2, and -7G5 displayed bands with the size of the parental v-GR. Addition of tunicamycin during 35 S labeling yielded a single 37-kDa band, corresponding to the nonglycosylated core protein (data not shown). Thus, the different banding was due to differential glycosylation in the extracellular, membrane-proximal third of the mtv-7 and GR SAgs. SAg bands were weaker for v-7, v-7G2, and v-7G6 and especially v-7G1 than for v-7G3, -7G4, -7G5, and v-GR. Despite the different intensity of their bands, v-7 and v-GR induced similar stimulation of specific CD4 ϩ T cells (Fig. 3 ). Since the different intensity of the bands strictly segregated with the C-terminal third of the SAgs, it was most likely caused by the anti-SAg antiserum recognizing the mtv-7 SAg less efficiently than the GR SAg. Indeed, this anti-SAg antiserum (serum C [3] ) was raised against a synthetic 23-amino-acid (aa) peptide of the GR SAg (aa 262 to 284), which has a 3-aa difference with the corresponding mtv-7 SAg peptide. We concluded that our rVVs express a SAg of the appropriate size at similar levels in tissue culture, except for v-7G1, which exhibits a slightly weaker expression.
All rVVs were subsequently tested in I-E ϩ I-A ϩ (BALB/c or C57BL/6 I-E␣ tg) and I-E Ϫ I-A ϩ (C57BL/6) mice under previously determined optimal conditions (data not shown). One day after infection with 10 6 PFU, draining popliteal lymph nodes were analyzed for the expansion of mtv-7-specific V␤6 35 S]Met-Cys at 12 h postinfection as described earlier (2, 5) . Cells were lysed with radioimmunoprecipitation assay buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, and 50 mM Tris-HCl, pH 8) containing protease inhibitors (0.2 mM phenylmethylsulfonyl fluoride, 10 g of aprotinin/ml, and 10 g of leupeptin/ml) and were clarified by centrifugation. All samples were normalized for 35 S counts per minute before preclearing with preimmune rabbit serum and protein G-agarose beads (Amersham Pharmacia Biotech, Uppsala, Sweden). MMTV SAgs were then immunoprecipitated with a polyclonal rabbit anti-MMTV(GR) peptide serum (serum C [3] ) and protein-G agarose beads. Samples were resolved on a sodium dodecyl sulfate-10% polyacrylamide gel electrophoresis under reducing conditions. A VV wild-type-infected sample (wt) was used as a negative control.
induced SAg responses similar to v-GR. These results demonstrate that all rVVs produce parental/hybrid molecules with intact SAg function that, except for v-7G1, induce quantitatively similar SAg responses in I-E ϩ mice (200 to 250% of normal control). Thus, all hybrid SAgs adopt a three-dimensional conformation that allows correct transport to the cell surface, association and presentation with I-E, and recognition by the specific T-cell receptor V␤ chains as the two parental SAgs.
In I-E Ϫ mice, v-GR induced a barely detectable increase of specific V␤14 ϩ and nonspecific V␤6 ϩ CD4 ϩ lymphoblasts, demonstrating the I-E dependence of the MMTV(GR) SAgspecific response under these conditions. In contrast, v-7, -7G2, -7G6, and 7G1, despite a lower lever of SAg expression, induced a significant increase in the percentage of V␤6 ϩ CD4 ϩ T cells, though at different levels, when compared to uninjected mice and to mice injected with v-GR (Fig. 3B) . Most importantly, v-7G2 induced a SAg response with the same efficiency as v-7. When v-7G3, -7G4, and v-7G5 were injected into I-E Ϫ mice, only v-7G3 was able to efficiently stimulate V␤14 ϩ CD4 ϩ T cells, whereas v-7G4 and v-7G5 gave SAg responses similar to that of v-GR. Based on the comparison with GR of their ability to stimulate CD4 ϩ T cells in the absence of I-E, irrespective of their V␤ specificity, our hybrid SAgs can be divided into two groups: hybrids 7G1, 7G2, 7G3 and 7G6 behave like I-E-independent SAgs and can be presented by MHC class II I-A, though with different efficiencies, whereas hybrids 7G4 and 7G5 behave as I-E-dependent SAgs.
Our results demonstrate a dominant contribution of the C-terminal third of mtv-7 SAg in the association with I-A in an in vivo setting (7G2). This reveals a major site of interaction with I-A in the C-terminal 111 aa (aa 212 to 322) or more precisely, in the C-terminal 90 aa, due to the lack of amino acid difference between GR and mtv-7 (Fig. 1) . Previous biochemical analyses have indeed proposed a binding site for MHC class II HLA-DR, the human homologue of I-E, in the Cterminal 18.5-kDa fragment of mtv-7 (10) . Here, we further show that separately, the membrane-proximal (7G4) and the
FIG. 3. SAg responses induced by rVV expressing hybrid mtv-7/GR SAgs in I-E
ϩ and I-E Ϫ mice. I-E ϩ mice (BALB/c or C57BL/6 I-E␣ tg [7] ) and I-E Ϫ mice (C57BL/6) (Harlan OLAC Ltd., Bicester, United Kingdom) were injected subcutaneously in the hind footpads with rVV (10 6 PFU in a 30-l volume). Twenty hours postinjection the mice were sacrificed, and the draining popliteal lymph nodes were isolated and homogenized to a single-cell suspension. Cells were stained with a mixture of the given anti-V middle (7G5) thirds of the extracellular domain of the mtv-7 SAg do not support interaction with I-A, but they do so when combined (7G3). This suggests either that both the membraneproximal and middle thirds of the SAg contain structures that cooperate for association with I-A and/or that one site mediating I-A interaction overlaps the junction of the two thirds around aa 122. Previous studies by others addressed MHC class II binding sites in the membrane-proximal third. Using competition assays for peptide binding, aa 76 to 119 of the mtv-1 SAg were identified as a common binding site for I-E and I-A, even though the function of mtv-1 SAg is I-E dependent in vivo (11) . Mutagenesis analyses showed, however, that amino acids surrounding residue K109 were not involved in the interaction with MHC class II (9) . Another recent report further suggested that aa 86 to 94 are necessary but not sufficient for the association of MMTV SAgs with I-E, in a manner similar to that of the invariant chain (4). Based on the lack of correlation between I-E dependence and amino acid variability at SAg residues 86 to 94 and on the observation that all our wild-type and hybrid SAgs show intact SAg function, when presented by I-E, we propose that all I-E-dependent and -independent viral SAgs can interact with I-E and I-A via residues 86 to 94. Since this interaction is not sufficient, other binding sites with differential affinities for I-E versus I-A, thereby determining the I-E dependence or independence of a SAg, are required for stable association with I-E or I-A, as shown in this paper. Although in full agreement with the studies of Hsu et al. (4) and Torres et al. (11) , our approach does not address common binding sites for I-E and I-A, such as aa 86 to 94.
In conclusion, our results are compatible with the idea that different binding sites on the mtv-7 SAg cooperate for efficient association with MHC class II I-A (4). Alternatively, we cannot exclude the possibility that nonlinear structures in the GR SAg impede I-A but not I-E binding directly or indirectly by changing the overall three-dimensional conformation of the molecule.
